The latest KnowItAll software accelerates spectral analysis, featuring automated LC-MS tools and extensive spectral libraries to optimize research workflows.
New study explores obecabtagene autoleucel for adults with hard-to-treat leukemia
FELIX study results reveal obe-cel’s potential in relapsed B-cell ALL, achieving 77% remission with low severe toxicity, enhancing CAR T-cell therapy outcomes.